Abstract
Background
The peptide antibiotic viomycin inhibits ribosomal protein synthesis, group I intron self-splicing and self-cleavage of the human hepatitis delta virus ribozyme. To understand the molecular basis of RNA binding and recognition by viomycin, we isolated a variety of novel viomycin-binding RNA molecules using in vitro selection.Results
More than 90% of the selected RNA molecules shared one continuous highly conserved region of 14 nucleotides. Mutational analyses, structural probing, together with footprinting experiments by chemical modification, and Pb2+-induced cleavage showed that this conserved sequence harbours the antibiotic-binding site and forms a stem-loop structure. Moreover, the loop is engaged in a long-range interaction forming a pseudoknot.Conclusions
A comparison between the novel viomycin-binding motif and the natural RNA target sites for viomycin showed that all these segments form a pseudoknot at the antibiotic-binding site. We therefore conclude that this peptide antibiotic has a strong selectivity for particular RNA pseudoknots.References
Articles referenced by this article (40)
Recognition sites for antibiotics within rRNA
1990
Non-competitive inhibition of group I intron RNA self-splicing by aminoglycoside antibiotics.
J Mol Biol, (4):935-941 1992
MED: 1518063
Peptide antibiotics of the tuberactinomycin family as inhibitors of group I intron RNA splicing.
J Mol Biol, (4):1001-1010 1994
MED: 7509881
The pseudodisaccharides: a novel class of group I intron splicing inhibitors.
Nucleic Acids Res, (23):4983-4988 1994
MED: 7800490
Enhancement of Neurospora VS ribozyme cleavage by tuberactinomycin antibiotics.
EMBO J, (13):3247-3251 1995
MED: 7621836
Inhibition of the self-cleavage reaction of the human hepatitis delta virus ribozyme by antibiotics.
J Mol Biol, (5):916-925 1996
MED: 8683594
Interaction of aminoglycoside antibiotics with RNA
1996
Show 10 more references (10 of 40)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Article citations
Predicting Future Prospects of Aptamers in Field-Effect Transistor Biosensors.
Molecules, 25(3):E680, 05 Feb 2020
Cited by: 10 articles | PMID: 32033448 | PMCID: PMC7036789
Studies of viomycin, an anti-tuberculosis antibiotic: copper(ii) coordination, DNA degradation and the impact on delta ribozyme cleavage activity.
Dalton Trans, 45(20):8645-8658, 01 May 2016
Cited by: 5 articles | PMID: 27143296
Aptamers: new arrows to target dendritic cells.
J Drug Target, 24(1):1-12, 07 May 2015
Cited by: 11 articles | PMID: 25950603
Clinical applications of nucleic acid aptamers in cancer.
Mol Clin Oncol, 2(3):341-348, 10 Feb 2014
Cited by: 30 articles | PMID: 24772298 | PMCID: PMC3999129
Review Free full text in Europe PMC
Challenges and opportunities for small molecule aptamer development.
J Nucleic Acids, 2012:748913, 24 Oct 2012
Cited by: 160 articles | PMID: 23150810 | PMCID: PMC3488411
Go to all (21) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
The antibiotic viomycin as a model peptide for the origin of the co-evolution of RNA and proteins.
Orig Life Evol Biosph, 29(4):391-404, 01 Aug 1999
Cited by: 4 articles | PMID: 10472628
The translocation inhibitor tuberactinomycin binds to nucleic acids and blocks the in vitro assembly of 50S subunits.
Nucleic Acids Res, 8(23):5767-5777, 01 Dec 1980
Cited by: 7 articles | PMID: 6258151 | PMCID: PMC324340
Antibiotic-induced oligomerisation of group I intron RNA.
J Mol Biol, 258(1):53-61, 01 Apr 1996
Cited by: 8 articles | PMID: 8613991
New developments in structure determination of pseudoknots.
Biopolymers, 48(2-3):137-153, 01 Jan 1998
Cited by: 34 articles | PMID: 10333742
Review
